Mahathir Bayena

Janus Electric (ASX:JNS) appointed Ton van Hoof as its CFO, effective March 23.

Recce Pharmaceuticals (ASX:RCE) has been granted a Family 4 patent for its proprietary synthetic anti-infectives.

Sparc Technologies (ASX:SPN) signs LOI with HydroGraph Clean Power to integrate "Fractal Graphene" into ecosparc protective coatings.

Stakk (ASX:SKK) announced its largest individual client contract to date, worth $7.9 million.

Trian Fund Management and General Catalyst Group Management today announced a definitive amendment to their merger agreement with Janus Henderson Group (NYSE:JHG), raising the acquisition price to $52 per share in cash.

LENZ Therapeutics (NASDAQ:LENZ) today reported its financial results for the fourth quarter and full year ended December 31, 2025, providing the first comprehensive look at the commercial performance of VIZZ® (aceclidine 1.44%).

Fennec Pharmaceuticals (NASDAQ:FENC) today reported its financial results for the fourth quarter and full year ended December 31, 2025, highlighting a year of aggressive commercial scaling and a total recapitalization of the company’s balance sheet.

BioNTech (NASDAQ:BNTX) announced today its comprehensive participation in the European Lung Cancer Congress (ELCC) 2026, where the company will present updated data across its diversified lung cancer portfolio.

AerCap Holdings (NYSE:AER), the world’s largest aircraft lessor, has announced the signing of lease agreements with Ethiopian Airlines for two Boeing 777-300ERSF converted freighters.

Smith-Midland (NASDAQ:SMID) today provided a preliminary look at its fourth quarter and full-year 2025 performance, signaling what is expected to be the most profitable year in the company’s history.